Clinical Trial Update: Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating adenosine-induced myocardial blood flow in patients with peripheral artery disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Occlusive Disease
• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• Adenosine (Adenosine)

Snippet

Sponsor: AstraZeneca | Conditions: Peripheral Artery Disease, Vascular Disease | Phase 4 | Status: WITHDRAWN